As a pivotal advance in the gene-editing field and timeline, CRISPR continues to be utilized for research on stem cells and human diseases. Today, I will explain some of the most notable recent findings in the stem cell-CRISPR field. To start things off, I have also created an infographic that briefly explains what CRISPR-Cas9 is, […]
New research on CRISPR gene-editing in stem cells, infographic Read More »
Should California’s Stem Cell Agency, more widely known as CIRM, get another round of funding from us California voters? I believe the answer is yes and I endorse Proposition 14, which would provide the funding for CIRM to translate dozens of clinical trials into some proven new stem cell-based treatments in the coming decade. However,
Seth Rogen is a stem cell pitching Prop 14 for CIRM in funny new video Read More »
More states have taken action against stem cell clinic-related firms in the past year than ever before and now we can add Georgia to the list. Georgia adds to growing list of state AGs suing stem cell clinics The George Attorney General Chris Carr filed suit against several related firms (going by various names over
Georgia AG sues clinics & owner Justin Paulk Read More »
It’s helpful for me to learn about the readers of this blog The Niche in terms of who you are and your backgrounds. Because some people may want to vote more than once on the types of posts they like the most, I’ve allowed re-voting on that poll. Free stuff Those who participate and leave
Enter the Niche Reader Survey for chance at free stem cell swag Read More »
Introduction to CAR-T cells CAR-T cells are an exciting cutting-edge technology that has been garnering great interest including in the stem cell field. Potential therapeutic uses of CAR-T, which stands for Chimeric Antigen Receptor T-Cells (CAR-T), are being studied in clinical trials as immunotherapies to potentially fight cancer as well as many other diseases by
CAR-T cells review: cancer & a critical look at possible uses in aging & COVID-19 Read More »
The FTC has sharply increased its oversight activities against stem cell and regenerative clinic firms. These new actions include quite a few warning letters. Here is the FTC database for COVID-19-related warning letters. Note that recently the FTC added a new, helpful option to view all of its warning letters here. It’s a good source
FTC fires off many warnings to stem cell clinics on COVID-19 Read More »
What’s been going on in the stem cell and regenerative medicine field over the past week and what are some worthwhile things to read? Today’s post has recommended recent reads from the scientific literature and the media. I’ve also got our weekly stem cell/regenerative medicine quiz question and the answer to last week’s. You can
Recommended reads: FDA warning, COVID updates, stem cell pubs Read More »
The FDA and its CBER branch have been doing a good job overall in the last 3+ years to tackle the unproven stem cell clinic problem, but lately on the stem cells for COVID-19 front there is reason for real concern. I believe the agency is taking on major risk overall by clearing a vast number of
Politics & FDA OK of 2 stem cell clinic COVID-19 efforts Read More »
What science and stem cell pubs are you reading right now and what do you hope to get too soon? Sometimes science means getting out in the field. Now there are no wild stem cells out there roaming the fields to catch and analyze, but there are other ways. A couple of my kids and
Weekly reads: Hox, exosome IND app, stem cell quiz, more Read More »
Many are jumping on the bandwagon of trying stem cells for COVID-19 or testing other cellular therapies for the novel coronavirus disease, but there have been problems with either the rationales for the trials themselves or more often with how they portrayed. Sometimes there has even been outright hype. I’ve called this collective trend of
Overselling stem cells for COVID-19: WSJ article & UMN PR Read More »